BlackRock Advisors’s BIND THERAPEUTICS INC BIND Stock Holding History

BlackRock Advisors’s Portfolio BIND Stock Details BIND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-19,875	Closed	-$44K	–	3906
2016 Q1	$44K	Sell	19,875 -3,775	-16%	-$6.84K	﹤0.01%	3200
2015 Q4	$54K	Hold	23,650	–	–	﹤0.01%	3163
2015 Q3	$105K	Sell	23,650 -80,745	-77%	-$396K	﹤0.01%	3082
2015 Q2	$584K	Sell	104,395 -1,619	-2%	-$10K	﹤0.01%	2066
2015 Q1	$582K	Hold	106,014	–	–	﹤0.01%	1970
2014 Q4	$572K	Buy	106,014 +5,227	+5%	+$39.2K	﹤0.01%	1901
2014 Q3	$866K	Sell	100,787 -27,647	-22%	-$273K	﹤0.01%	1525
2014 Q2	$1.69M	Sell	128,434 -2,935	-2%	-$28.7K	﹤0.01%	1224
2014 Q1	$1.57M	Buy	131,369 +117,605	+854%	+$1.54M	﹤0.01%	1277
2013 Q4	$208K	Buy	+13,764	New	+$175K	﹤0.01%	2636

Other funds holding BIND

PVMCV

Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

VKH

Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

FMA

FNY Managed Accounts New York $83.4M AUM 11.55% 1-Year Est. Return

Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return

BlackRock Advisors's BIND Position: Q2 2016 in Review

BlackRock Advisors sold out of BIND THERAPEUTICS INC (BIND) in Q2 2016, closing a stake of 19,875 shares — an estimated $44K sold.

BlackRock Advisors first reported a position in BIND in Q4 2013 and held it in 10 quarters. The position peaked at $1.69M in Q2 2014. 21 funds tracked by Wall St. Rank hold BIND as of Q2 2016.

BlackRock Advisors reported no remaining BIND THERAPEUTICS INC position as of Q2 2016 after selling out during the quarter.
BlackRock Advisors sold 19,875 BIND THERAPEUTICS INC shares in Q2 2016, an estimated $44K.
BlackRock Advisors first reported a position in BIND THERAPEUTICS INC in Q4 2013 and held it in 10 quarters.
BlackRock Advisors's BIND THERAPEUTICS INC position peaked at $1.69M in Q2 2014.
21 funds tracked by Wall St. Rank held BIND THERAPEUTICS INC as of Q2 2016.

Based on BlackRock Advisors's 13F filing for Q2 2016, filed 10 Aug 2016.